- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
Showing 1–12 of 55 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price | |
|---|---|---|---|---|---|---|---|---|---|---|
PlGF , VEGF-A , VEGF-B |
Fusion protein |
Zaltrap® |
25 mg/mL |
– |
2 mg |
tba |
tba |
229,00 € |
||
EGFR , MET |
Bispecific Antibody |
Rybrevant® |
50 mg/ml |
– |
7 mg |
-80°C |
11/2023 |
312,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
06/2018 |
238,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
09/2018 |
238,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
09/2018 |
238,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
12/2018 |
238,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
03/2019 |
238,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
08/2019 |
238,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
10/2019 |
238,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
yes |
2 mg |
-80°C |
03/2021 |
261,80 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
3 mg |
-80°C |
09/2017 |
327,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
3 mg |
-80°C |
03/2018 |
327,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
yes |
2 mg |
-80°C |
07/2024 |
238,00 € |
||
CD30 |
Antibody-drug conjugate (ADC) |
Adcetris® |
5 mg/mL |
– |
2 mg |
-80°C |
02/2025 |
888,00 € |
||
PD-1 |
Monoclonal Antibody |
Libtayo® |
50 mg/mL |
– |
5 mg |
tba |
tba |
381,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
11/2019 |
196,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
01/2020 |
196,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
05/2021 |
196,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
5 mg |
-80°C |
09/2021 |
421,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
11/2021 |
196,00 € |
||
CD33 |
Antibody-drug conjugate (ADC) |
Mylotarg® |
1 mg/mL |
– |
0,1 mg |
-80°C |
08/2024 |
862,00 € |
||
CD22 |
Antibody-drug conjugate (ADC) |
Besponsa® |
0,25 mg/mL |
– |
0,02 mg |
tba |
tba |
1.132,00 € |
||
CCR4 |
Monoclonal Antibody |
Poteligeo® |
4 mg/mL |
– |
0,5 mg |
-80 °C |
09/2023 |
340,00 € |
||
CD20 |
Monoclonal Antibody |
Gazyvaro® |
25 mg/mL |
– |
6 mg |
-80°C |
06/2019 |
491,00 € |
||
CD20 |
Monoclonal Antibody |
Gazyvaro® |
25 mg/mL |
– |
6 mg |
-80°C |
08/2019 |
491,00 € |
||
EGFR |
Monoclonal Antibody |
Vectibix® |
20 mg/mL |
– |
2 mg |
tba |
tba |
225,00 € |
||
HER2 |
Monoclonal Antibody |
Perjeta® |
30 mg/mL |
yes |
6 mg |
-80°C |
11/2020 |
557,00 € |
||
HER2 |
Monoclonal Antibody |
Phesgo® |
60 mg/mL |
– |
12 mg |
tba |
tba |
906,00 € |
||
CD79b |
Antibody-drug conjugate (ADC) |
Polivy® |
20 mg/mL |
– |
1 mg |
-80 °C |
06/2024 |
520,00 € |
||
VEGFR2 |
Monoclonal Antibody |
Cyramza® |
10 mg/mL |
– |
2 mg |
-80°C |
03/2018 |
234,00 € |
Let us know about your inquiry details and we’ll contact you shortly.
